Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,365 total articles
Marvell sits at the center of AI networking and storage. A strategic tie-up or acquisition of an optics specialist like POET would plug a gap in Marvell's data-center optics stack and could justify a material multiple expansion. This trade idea lays out a long entry, stop, targets, catalysts and risks with a primary horizon of 180 trading days.
INBX exploded higher on reports that large pharmas are in early talks about a joint spin-off of INBRX-106 and another oncology asset — a combination that analysts peg at multi-billion dollar value. The move ripped the stock from the low teens to intraday highs above $155 and leaves a tradable setup for momentum traders who respect biotech risk and …
The reopening of the Strait of Hormuz removed an immediate premium, but structural shifts in global supply, U.S. export dynamics, and Diamondback's capital returns argue that oil is unlikely to return to 'cheap' levels. Diamondback Energy (FANG) offers a leveraged, cash-returning way to play sustained mid-cycle oil prices—entry $193.00, stop $175.0…
Moody's (MCO) looks buyable after a strong mix of cash flow generation, best-in-class ROE, and improving momentum. The firm's rating franchise and Moody's Analytics provide recurring, high-margin revenue that supports a premium multiple. We lay out an actionable long trade with entry, stop and target framed to capture upside while keeping risk cont…
Xenon Pharmaceuticals' positive Phase 3 X-TOLE2 results for azetukalner (53.2% median seizure reduction vs 10.4% for placebo) and robust 48-month extension data justify a tactical long position. The company is well-capitalized after a $650M offering but trades at a premium - a buy for traders willing to accept biotech binary risk into an expected Q…
Buy LSEG (London Stock Exchange Group) as a mid-term swing trade. The business benefits from recurring fee streams, growing data and analytics monetization, and a resilient market structure that generates revenue regardless of direction. Enter at $95.00, stop $84.00, target $115.00. Time the trade for a mid-term hold (45 trading days) to let cataly…
MSOS has ripped higher after federal rescheduling optimism. The ETF's liquidity, concentration in U.S. operators, and immediate technical momentum create a tradable long setup. This note lays out an entry, stop, and target with framing on catalysts, valuation, and risks.
Alphabet is entering its April 29 earnings with accelerating AI adoption across Search and Cloud, a deep balance sheet and expanding custom chip partnerships that should support continued revenue and margin expansion. This trade idea outlines a mid-term swing buy with entry, stop and target, and a risk framework that balances headline risk around t…
Kyverna Therapeutics presents a binary, high-reward trade: additional proof-of-concept (POC) data for miv-cel in myasthenia gravis could materially re-rate the stock. With limited public financial disclosure at the time of writing, this is a catalyst-driven long where position sizing should reflect binary clinical risk.
Vertiv reported strong Q1 results — revenue +30% YoY to $2.65B, adjusted EPS $1.17, and margin expansion — yet the stock pulled back after the print. With a backlog that suggests years of demand and free cash flow of roughly $1.89B, the sell-off gives long-term investors a defined entry to participate in AI-driven data center infrastructure. The tr…
Nvidia is trading around $201.75 after a multi-year run and is presenting an actionable long opportunity: strong macro and product catalysts, massive free cash flow, and technical momentum despite a valuation that still prices in growth. This trade targets capturing the next AI-driven data center cycle with a clear entry at $201.75, a stop at $186.…
Pony AI is entering a critical growth phase in 2026: the company reported Q4 revenue of $29.1M, achieved Gen-7 robotaxi unit-economics breakeven in key Chinese cities, and is guiding to a material increase in robotaxi revenue as it scales to thousands of vehicles. This trade idea takes a long stance on PONY with a defined entry at $11.01, a $20.00 …
Abercrombie & Fitch has delivered a convincing operational rebound: strong cash flow, no net debt, and profitable growth at scale. Valuation is reasonable (EV/EBITDA ~4.1; P/E ~8.4), leaving room for upside if sales and margins hold. But management flagged heavier capital spending and tariff-related cost pressure, and recent guidance disappointed i…
AT&T (T) looks like a mid-cap telecom with a defensive cash flow profile trading at single-digit earnings multiples, a 4%+ yield and an EV/EBITDA under 7. That combination supports a tactical long trade over the next 45 trading days with a defined stop and a realistic upside target tied to re-rating catalysts.
Advanced Micro Devices has gone from turnaround story to AI beneficiary. Recent price action and newsflow point to meaningful GPU/server wins and accelerating data-center revenue. This trade idea outlines a long entry with clear stop and target levels across a 180-trading-day horizon, balancing upside from secular AI adoption against high absolute …
Intuitive Surgical posted a clean Q1 beat on 04/22/2026, raised da Vinci procedure growth and margin guidance, and showed continued cash generation. The stock trades at a premium but technicals and guidance suggest upside. This trade idea proposes a long entry at $486.00 with a $575.00 target over 180 trading days and a $450.00 stop loss to limit d…
POET Technologies has moved past pure speculation toward concrete commercialization signals: production orders and partnerships with LITEON and Lessengers, plus corporate changes to address PFIC tax issues. Heavy volume, a compressed short-covering setup and accelerating technicals support a mid-term long trade. Risk is high given limited revenue h…
Aura Biosciences is trading near a 52-week high after a cash raise and steady clinical progress for belzupacap sarotalocan (bel-sar / AU-011). The company has runway into early 2027, a tighter float and improving technicals. This note lays out a mid-term (45 trading days) trade idea: a tactical long with specific entry, stop and target, and a balan…
Vaalco Energy just delivered concrete operational proof points in Gabon and readied a key Côte d'Ivoire FPSO for restart. With a $626M market cap, low leverage (debt/equity ~0.29), an attractive quarterly dividend ($0.0625) and an EV/EBITDA of 4.4, the stock is set up for a mid-term swing. This is a trade idea: enter $6.00, stop $5.35, target $8.00…
OR Royalties behaves like a toll booth on gold production: low operating cost, high optionality to metal prices, and recurring cash flows. With market quotes unavailable in the live feed, this trade idea sets a clear entry, stop, and target for a mid-term swing (45 trading days) aiming to capture re-rating and near-term project news while limiting …
RMR Group (RMR) offers a chunky cash yield and a conservative balance sheet. At roughly $16.56 today the stock trades at a mid-teens P/E and an EV/EBITDA near 4x. If fee revenue stabilizes and the market gives the stock even modest multiple expansion, there is meaningful upside to low-double-digit returns while collecting a high cash yield.
The recent wave of high-profile sports-team transactions — highlighted by the Padres sale — reinforces a thesis that sports franchises and their mixed-use real estate can command premium, asset-backed valuations. Atlanta Braves Holdings (BATRA) trades at $53.78 with a market cap near $3.45B and an enterprise value of about $4.18B. Given the Braves'…
Hydreight Technologies (HYDTF) is scaling a compliance-first mobile clinical platform through white-label medspa deals and a telemedicine stack that can be deployed across all 50 states. With record Q1 revenue of $4.87M (up 33% YoY), audited FY2023 filings, and national distribution partners representing nearly 700 locations, the company shows real…
Marvell has moved from a low-profile infrastructure vendor to a central piece of AI data center stacks. Strategic partnerships (including a major Nvidia tie-up), strong profitability, and accelerating demand for networking and custom XPUs argue for a material re-rating. The valuation is rich, so the trade is structured with a clear entry, stop and …
Taboola (TBLA) is trading at attractive cash-flow multiples, above short- and medium-term moving averages, and benefits from recent AI/product partnerships. We lay out a long trade with exact entry, stop and target; valuation and catalysts support upside to $6 over a multi-month horizon while technical overbought signals and ad-market execution rem…
